Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|December 27, 2021
Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?Jenée Mitchell, George KannourakisFrontiers in Pediatrics|July 18, 2022
Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within LesionsJenée Mitchell, Egle Kvedaraite, Tatiana von Bahr Greenwood, et al.Scientific Reports|November 9, 2018
Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell HistiocytosisJenée Mitchell, Egle Kvedaraite, Tatiana von Bahr Greenwood, et al.Clinical Immunology (Orlando, Fla.)|April 14, 2020
Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacityJenée Mitchell, Jason Kelly, Egle Kvedaraite, et al.The Journal of General Virology|June 21, 2002
A time to kill: viral manipulation of the cell death programStewart Hay, George KannourakisClinical Immunology (Orlando, Fla.)|June 22, 2018
A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosisJenée M Mitchell, Stuart P Berzins, George KannourakisFrontiers in Medicine|July 1, 2022
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell CarcinomaRevati Sharma, George Kannourakis, Prashanth Prithviraj, et al.Cell Communication and Signaling : CCS|May 18, 2021
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrenceTamsin Wesley, Stuart Berzins, George Kannourakis, et al.Cancers|December 17, 2024
Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico DatasetsTamsin Wesley, Ruth M Escalona, George Kannourakis, et al.Pageof 7